|Ms. Kristin C. Peck||CEO & Director||2.8M||3.05M||1971|
|Mr. Wetteny N. Joseph||Exec. VP & CFO||1.26M||N/A||1972|
|Ms. Wafaa Mamilli||EVP, Chief Digital & Tech. Officer, Group Pres for China, Brazil and Preci. Animal Health||1.08M||N/A||1967|
|Ms. Heidi C. Chen||Exec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics||1.04M||N/A||1967|
|Ms. Roxanne Lagano||Exec. VP and Chief HR Officer & Global Operations||N/A||N/A||1965|
|Mr. Steven Frank||VP of Investor Relations||N/A||N/A||N/A|
|Mr. William Price||VP & Chief Communications Officer||N/A||N/A||N/A|
|Dr. Robert J. Polzer Ph.D.||Exec. VP and Pres of R&D||N/A||N/A||1969|
|Ms. Jeannette Ferran Astorga||Exec. VP of Corp. Affairs & Communications and Chief Sustainability Officer||N/A||N/A||1975|
|Mr. Nick Ashton||Exec. VP and Pres of Global Manufacturing & Supply||N/A||N/A||1973|
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Zoetis Inc.’s ISS governance QualityScore as of 1 September 2023 is 2. The pillar scores are Audit: 5; Board: 1; Shareholder rights: 7; Compensation: 2.